This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Safe and growing: Four dividend stocks that act like growth stocks

Stocks in this article: AGNC AZN ORAN TI

By Robbie Citrino for Kapitall.

The typical income stock is a conglomerate whose share price rarely moves, whose business model is steady, and whose dividend pays over 5%. The following five stocks, however, have broken this mold and returned more than 20% this year.

AstraZenica (AZN), the London-based pharmaceutical company rode the biotech boom this year, jumping 24% in six months while holding its 5.22% dividend steady for investors.

Orange (ORAN), a technology solutions and telecom firm based in Paris that currently returns 8% to shareholders in a semiannual dividend. It rose nearly 38% over the course of two quarters by beating analysts' estimates and by earning analysts' upgrades.

The Italian telecom giant, Telecom Italia SpA (TI), has tacked on a whopping 8.9 billion in market cap (or 44%) since December in addition to the 8.8% shareholders received from its dividend despite being downgraded by a variety of analysts.

Rebounding from yearly lows in December, American Capital Agency Corp (AGNC), an American residential REIT has posted solid gains upwards of 20% as analysts pushed their price targets into higher territory. All the while, it kept its staggering 11% dividend in place to entice investors.

These four stocks are exemplary models of what investors are looking for; however, can their share price keep climbing, or will they return to acting like the typical income stock?

Can one investor have it all? Use the links below to start your own research, and tell us what you think in the comments! 

Click on the interactive chart to view data over time. 


1. AstraZeneca PLC ( AZN, Earnings, Analysts, Financials): Develops, and commercializes prescription medicines for cardiovascular, gastrointestinal, infection, neuroscience, oncology, and respiratory and inflammation diseases worldwide. Market cap at $85.33B, most recent closing price at $68.05.


1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,356.87 +288.00 1.69%
S&P 500 2,012.89 +40.15 2.04%
NASDAQ 4,644.3120 +96.4780 2.12%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs